エドガーで原本を確認する
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or Other Jurisdiction | (Commission | (IRS Employer | ||
| of Incorporation) | File Number) | Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s
telephone number, including area code:
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).
Emerging
growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Glucotrack, Inc., a Delaware corporation (the “Company”), filed with the Delaware Secretary of State a Certificate of Amendment to the Certificate of Incorporation of the Company (the “Certificate of Amendment”), which became effective at 4:30 p.m., Eastern Time, on August 28, 2026 (the “Effective Time”), to effect a one-for-fifteen (1-for-15) reverse stock split (the “Reverse Stock Split”) of the shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The Reverse Stock Split was approved by the Company’s stockholders at the 2026 annual meeting of the stockholders on August 18, 2026.
As a result of the Reverse Stock Split, every 15 shares of issued and outstanding Common Stock were automatically combined into one (1) issued and outstanding share of Common Stock, without any change in the par value per share. No fractional shares were issued as a result of the Reverse Stock Split. Instead, stockholders who otherwise would have been entitled to receive fractional shares because they held a number of shares not evenly divisible by the Reverse Stock Split ratio were entitled to receive an additional fraction of a share of Common Stock to round up to the next whole share. The Reverse Stock Split did not change the total number of authorized shares of Common Stock, which remains 250,000,000 shares.
Following the Reverse Stock Split, the number of shares of Common Stock outstanding was proportionally reduced from 11,972,157 shares to approximately 798,144 shares as of immediately prior to the Effective Time. The shares of Common Stock underlying the Company’s outstanding stock options and warrants were similarly adjusted along with corresponding adjustments to their exercise prices.
The Company’s transfer agent, VStock Transfer, LLC, is acting as the exchange agent for the Reverse Stock Split and will send each stockholder of record a transaction statement indicating the number of shares of Common Stock the stockholder holds after the Reverse Stock Split. Stockholders owning shares via a broker or other nominee will have their positions automatically adjusted to reflect the Reverse Stock Split.
The Common Stock will begin trading on a reverse stock split-adjusted basis upon market open on August 31, 2026. The ticker symbol for the Common Stock will remain “GCTK.” The new CUSIP number for the Common Stock following the Reverse Stock Split will be 45824Q887.
The foregoing description of the Certificate of Amendment does not purport to be complete and is subject to, and is qualified in its entirety by reference to, the full text of the Certificate of Amendment which is attached as Exhibit 3.1 to this Current Report on Form 8-K, and is incorporated herein by reference.
Item 8.01 Other Events
The tables below set forth the impact of the Reverse Stock Split on the Company’s net loss per common share - basic and diluted; weighted average common shares outstanding - basic and diluted; and shares issued and outstanding, for the years ended December 31, 2025 and 2024, the three months ended March 31, 2026 and 2025, the three months ended June 30, 2026 and 2025, and the six months ended June 30, 2026 and 2025.
|
In thousands of US Dollars (except share and per share amounts) |
||||||||||||||||
| PRE SPLIT (1) | POST SPLIT (1) | |||||||||||||||
| YEAR ENDED DECEMBER 31, | YEAR ENDED DECEMBER 31, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Comprehensive net loss | $ | 19,339 | $ | 22,573 | $ | 19,339 | $ | 22,573 | ||||||||
| Net loss per common share - basic | $ | 31.22 | $ | 4,106 | $ | 468.30 | $ | 61,590 | ||||||||
| Net loss per common share - diluted | $ | 31.22 | $ | 4,106 | $ | 468.30 | $ | 61,590 | ||||||||
| Weighted average common shares outstanding - basic | 621,094 | 5,503 | 41,406 | 367 | ||||||||||||
| Weighted average common shares outstanding - diluted | 621,094 | 5,503 | 41,406 | 367 | ||||||||||||
| Common stock outstanding at year end | 910,688 | 13,409 | 60,713 | 894 | ||||||||||||
|
In thousands of US Dollars (except share and per share amounts) |
||||||||||||||||
| PRE SPLIT (2) | POST SPLIT (2) | |||||||||||||||
| 3 MONTHS ENDED MARCH 31, | 3 MONTHS ENDED MARCH 31, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Comprehensive net loss | $ | 4,331 | $ | 6,797 | $ | 4,331 | $ | 6,797 | ||||||||
| Net loss per common share - basic | $ | 2.65 | $ | 40.14 | $ | 39.75 | $ | 602.10 | ||||||||
| Net loss per common share - diluted | $ | 2.65 | $ | 40.14 | $ | 39.75 | $ | 602.10 | ||||||||
| Weighted average common shares outstanding - basic | 1,638,128 | 169,345 | 109,209 | 11,290 | ||||||||||||
| Weighted average common shares outstanding - diluted | 1,638,128 | 169,345 | 109,209 | 11,290 | ||||||||||||
| Common stock outstanding at period end | 2,524,279 | 426,431 | 168,285 | 28,429 | ||||||||||||
|
In thousands of US Dollars (except share and per share amounts) |
||||||||||||||||
| PRE SPLIT (3) | POST SPLIT (3) | |||||||||||||||
| 3 MONTHS ENDED JUNE 30, | 3 MONTHS ENDED JUNE 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Comprehensive net loss | $ | 3,806 | $ | 4,727 | $ | 3,806 | $ | 4,727 | ||||||||
| Net loss per common share - basic | $ | 0.76 | $ | 9.62 | $ | 11.40 | $ | 144.30 | ||||||||
| Net loss per common share - diluted | $ | 0.76 | $ | 9.62 | $ | 11.40 | $ | 144.30 | ||||||||
| Weighted average common shares outstanding - basic | 5,009,085 | 494,504 | 333,939 | 32,967 | ||||||||||||
| Weighted average common shares outstanding - diluted | 5,009,085 | 494,504 | 333,939 | 32,967 | ||||||||||||
| Common stock outstanding at period end | 6,259,279 | 899,410 | 417,285 | 59,961 | ||||||||||||
|
In thousands of US Dollars (except share and per share amounts) |
||||||||||||||||
| PRE SPLIT (3) | POST SPLIT (3) | |||||||||||||||
| 6 MONTHS ENDED JUNE 30, | 6 MONTHS ENDED JUNE 30, | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Comprehensive net loss | $ | 8,137 | $ | 11,524 | $ | 8,137 | $ | 11,524 | ||||||||
| Net loss per common share - basic | $ | 2.44 | $ | 34.81 | $ | 36.60 | $ | 522.15 | ||||||||
| Net loss per common share - diluted | $ | 2.44 | $ | 34.81 | $ | 36.60 | $ | 522.15 | ||||||||
| Weighted average common shares outstanding - basic | 3,332,919 | 332,931 | 222,195 | 22,195 | ||||||||||||
| Weighted average common shares outstanding - diluted | 3,332,919 | 332,931 | 222,195 | 22,195 | ||||||||||||
| Common stock outstanding at period end | 6,259,279 | 899,410 | 417,285 | 59,961 | ||||||||||||
| (1) | The pre-split amounts represent the amounts reported in the Company’s Form 10-K filed on March 30, 2026. The post-split amounts include the effects of the 1 for 15 reverse stock split completed in August 2026. |
| (2) | The pre-split amounts represent the amounts reported in the Company’s Form 10-Q filed on May 14, 2026. The post-split amounts include the effects of the 1 for 15 reverse stock split completed in August 2026. |
| (3) | The pre-split amounts represent the amounts reported in the Company’s Form 10-Q filed on August 14, 2026. The post-split amounts include the effects of the 1 for 15 reverse stock split completed in August 2026. |
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
|
Exhibit No. |
Description | |
| 3.1 | Certificate of Amendment to Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on August 28, 2026. | |
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: August 28, 2026 | ||
| GLUCOTRACK, INC. | ||
| By: | /s/ Erik Emerson | |
| Name: | Erik Emerson | |
| Title: | Chief Executive Officer | |
Exhibit 3.1
CERTIFICATE OF AMENDMENT TO
CERTIFICATE OF INCORPORATION
OF GLUCOTRACK, INC.
Glucotrack, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows:
1. The name of the Corporation is Glucotrack, Inc.
2. The Certificate of Incorporation of the Corporation is amended by replacing Article IV with the following:
“The total number of shares of common stock which the Corporation is authorized to issue is 250,000,000 shares, par value $0.001 per share (“Common Stock”), and the total number of shares of preferred stock which the Corporation is authorized to issue is 10,000,000 shares, par value $0.001 per share.
The Board of Directors of the Corporation is hereby expressly authorized to provide, out of the unissued shares of preferred stock, for one or more series of preferred stock and, with respect to each such series, to fix the number of shares constituting such series and the designation of such series, the voting powers, if any, of the shares of such series, and the preferences and relative, participating, optional or other special rights, if any, and any qualifications, limitations or restrictions thereof, of the shares of such series. The powers, preferences and relative, participating, optional and other special rights of each series of preferred stock, and the qualifications, limitations or restrictions thereof, if any, may differ from those of any and all other series at any time outstanding.
Upon the filing and effectiveness (the “Effective Time”) of this amendment to the Corporation’s Certificate of Incorporation, as amended, pursuant to the Delaware General Corporation Law, each fifteen (15) shares of the Common Stock issued immediately prior to the Effective Time (the “Old Common Stock”) shall be reclassified and combined into one validly issued, fully paid and non-assessable share of the Corporation’s Common Stock, $0.001 par value per share (the “New Common Stock”), without any action by the holder thereof, subject to the treatment of fractional share interests as described below (the “Reverse Stock Split”). No fractional shares of New Common Stock shall be issued as a result of the Reverse Stock Split and, any person who would otherwise be entitled to a fractional share of New Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall be entitled to receive a whole share of New Common Stock in lieu of any fractional share created as a result of such Reverse Stock Split. Each book entry position that theretofore represented shares of Old Common Stock shall thereafter represent that number of shares of New Common Stock into which the shares of Old Common Stock represented by such book entry position shall have been reclassified and combined; provided, that each person holding of record a book entry position that represented shares of Old Common Stock shall receive, a new book entry position evidencing and representing the number of shares of New Common Stock to which such person is entitled under the foregoing reclassification and combination.
The Reverse Stock Split shall not affect the total number of shares of capital stock, including the Common Stock, that the Corporation is authorized to issue, which shall remain as set forth under this Article IV.”
3. This Certificate of Amendment has been duly adopted by the Board of Directors and stockholders of the Corporation in accordance with Section 242 of the General Corporation Law of the State of Delaware.
4. This Certificate of Amendment shall become effective as of 4:30 p.m., Eastern Time on August 28, 2026.
IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed in its corporate name as of the 28th day of August, 2026.
| GLUCOTRACK, INC. | ||
| By: | /s/ Erik Emerson | |
| Name: | Erik Emerson | |
| Title: | Chief Executive Officer | |